Andere Sprachen Minerva Neurosciences, Inc.

Aktien

A3DMH5

US6033802058

NERV

Verzögert Nasdaq Andere Börsenplätze 18:21:30 26.04.2024			% 5 Tage	% 1. Jan.
2.46 ^USD	+1.23%		-0.81%	-60.00%

27.02.	Sektor-Update: Aktien des Gesundheitswesens geben am späten Nachmittag nach	MT
27.02.	Top Absteiger am Mittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sector Update: Health Care Stocks Ease Late Afternoon	27.02.
Top Midday Decliners	27.02.
Sector Update: Health Care Stocks Decline Tuesday Afternoon	27.02.
Minerva Neurosciences Shares Tumble After FDA Rejects Roluperidone for Schizophrenia.	27.02.
Minerva Neurosciences Shares Slide on Latest FDA Roluperidone Setback	27.02.
FDA Turns Away Minerva's Roluperidone Schizophrenia Drug	27.02.
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia	27.02.
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia	27.02.
Minerva Neurosciences: Q4 Earnings Snapshot	22.02.
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates	22.02.
Minerva Neurosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.02.
Minerva Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.02.
Minerva Neurosciences: Q3 Earnings Snapshot	07.11.
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates	07.11.
Minerva Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07.11.
Minerva Neurosciences : Aug 15, 2023	15.08.23
Minerva Neurosciences: Q2 Earnings Snapshot	01.08.23
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates	01.08.23
Minerva Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01.08.23
Sector Update: Health Care Stocks Declining Late Wednesday	28.06.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Minerva Neurosciences, Inc.

Aktien

A3DMH5

US6033802058

NERV

Andere Sprachen

Filter